ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.

Faucheux, B. A., Nillesse, N., Damier, P., Spik, G., Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 217

Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease

Davis, J. W., Grandinetti, A., Waslien, C., Ross, G. W., White, L. R., & Morens, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008954 · Cited by 216

Mechanisms of Copper Ion Mediated Huntington's Disease Progression

Fox, J. H., Kama, J. A., Lieberman, G., Chopra, R., Dorsey, K., Chopra, V., Volitakis, I., Cherny, R. A., Bush, A. I., & Hersch, S. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000334 · Cited by 220

Region‐specific disturbed iron distribution in early idiopathic P arkinson's disease measured by quantitative susceptibility mapping

He, N., Ling, H., Ding, B., Huang, J., Zhang, Y., Zhang, Z., Liu, C., Chen, K., & Yan, F. (2015) · Human Brain Mapping · doi:10.1002/hbm.22928 · Cited by 222

Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein

Golts, N., Snyder, H. M., Frasier, M. A., Theisler, C. M., Choi, P., & Wolozin, B. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 221

Brain iron deposition is linked with cognitive severity in Parkinson’s disease

Thomas, G. E. C., Leyland, L., Schrag, A. E., Lees, A. J., Acosta‐Cabronero, J., & Weil, R. S. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322042 · Cited by 211

Multiple System Atrophy: A Sporadic Synucleinopathy

Dickson, D. W., Lin, W.-L., Liu, W.-K., & Yen, S.-H. C. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00553.x · Cited by 212

MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects

Bartzokis, G., Cummings, J. L., Markham, C. H., Marmarelis, P. Z., Treciokas, L. J., Tishler, T. A., Marder, S. R., & Mintz, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00155-6 · Cited by 219

Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements

Wang, J., Zhuang, Q.-Q., Zhu, L.-B., Zhu, H., Li, T., Li, R., Chen, S., Huang, C.-P., Zhang, X., & Zhu, J. (2016) · Scientific Reports · doi:10.1038/srep36669 · Cited by 210

Iron, myelin, and the brain: neuroimaging meets neurobiology

Möller, H. E., Bossoni, L., Connor, J. R., Crichton, R. R., Does, M. D., Ward, R. J., Zecca, L., Zucca, F. A., & Ronen, I. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.009 · Cited by 207

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease

Lotfipour, A. K., Wharton, S., Schwarz, S. T., Gontu, V. K., Schäfer, A., Peters, A. M., Bowtell, R. W., Auer, D. P., Gowland, P. A., & Bajaj, N. P. S. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22752 · Cited by 210

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy

Jellinger, K. A. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170397 · Cited by 218

Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities

Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208

The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease

Acosta‐Cabronero, J., Cárdenas‐Blanco, A., Betts, M. J., Butryn, M., Valdés-Herrera, J. P., Galazky, I., & Nestor, P. J. (2016) · Brain · doi:10.1093/brain/aww278 · Cited by 199

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Franco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 197

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

Nguyen, T., Hamby, A., & Massa, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502177102 · Cited by 194

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

Weinreb, O., Mandel, S. A., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 199

Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin

Quintana, C., COWLEY, J. M., & Marhic, C. (2004) · Journal of Structural Biology · doi:10.1016/j.jsb.2004.03.001 · Cited by 189

Mammalian copper homeostasis: physiological roles and molecular mechanisms

Lutsenko, S., Roy, S., & Tsvetkov, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00011.2024 · Cited by 211

Metal ions as modulators of protein conformation and misfolding in neurodegeneration

Leal, S. S., Botelho, H. M., & Gomes, C. M. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.004 · Cited by 187

Brain Iron Metabolism Dysfunction in Parkinson’s Disease

Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 188

Iron toxicity in neurodegeneration

Núñez, M. T., Urrutia, P. J., Mena, N. P., Aguirre, P., Tapia, V., & Salazar, J. (2012) · BioMetals · doi:10.1007/s10534-012-9523-0 · Cited by 183

The comparative biology of neuromelanin and lipofuscin in the human brain

Double, K. L., Dedov, V. N., Fedorow, H., Kettle, E., Halliday, G. M., Garner, B., & Brunk, U. T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7581-9 · Cited by 181

Antioxidant gene therapy against neuronal cell death

Navarro-Yepes, J., Zavala-Flores, L. M., Anandhan, A., Wang, F., Skotak, M., Chandra, N., Li, M., Pappa, A., Martínez‐Fong, D., Razo, L. M. D., et al. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.007 · Cited by 182

Neuroinflammation in Huntington’s disease

Möller, T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0430-7 · Cited by 180

Occupational Exposure to Welding Fume among Welders: Alterations of Manganese, Iron, Zinc, Copper, and Lead in Body Fluids and the Oxidative Stress Status

Li, G. J., Zhang, L.-L., Lu, L., Wu, P., & Zheng, W. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000116900.49159.03 · Cited by 176

Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging

Zheng, W., Nichol, H., Liu, S., Cheng, Y. N., & Haacke, E. M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.022 · Cited by 176

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine

Chen, J., Marks, E. S., Lai, B. C. H., Zhang, Z., Duce, J. A., Lam, L. Q., Volitakis, I., Bush, A. I., Hersch, S. M., & Fox, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077023 · Cited by 176

Zinc Signal in Brain Diseases

Portbury, S. D., & Adlard, P. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122506 · Cited by 175

Searching for a relationship between manganese and welding and Parkinson’s disease

Jankovic, J. J. (2005) · Neurology · doi:10.1212/01.wnl.0000166916.40902.63 · Cited by 175

α-synuclein aggregation and its modulation

Ghosh, D., Mehra, S., Sahay, S., Singh, P. K., & Maji, S. K. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.021 · Cited by 193

The role of ATP13A2 in Parkinson’s disease: clinical phenotypes and molecular mechanisms

Park, J., Blair, N. F., & Sue, C. M. (2015) · Movement Disorders · doi:10.1002/mds.26243 · Cited by 173

Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter

Sun, H., Walsh, A. J. L., Lebel, R. M., Blevins, G., Catz, I., Lu, J., Johnson, E. S., Emery, D. J., Warren, K. G., & Wilman, A. H. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.11.010 · Cited by 170

Iron dysregulation in movement disorders

Dušek, P., Jankovic, J. J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 175

Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up

Ulla, M., Bonny, J.-M., Ouchchane, L., Rieu, I., Claise, B., & Durif, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057904 · Cited by 167

Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

Liddell, J. R. (2017) · Antioxidants · doi:10.3390/antiox6030065 · Cited by 172

T 2 relaxation time in patients with Parkinson's disease

Antonini, A., Leenders, K. L., Meier, D., Oertel, W. H., Boesiger, P., & Anliker, M. (1993) · Neurology · doi:10.1212/wnl.43.4.697 · Cited by 168

Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease

Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050071 · Cited by 167

Ceruloplasmin and what it might do

Healy, J., & Tipton, K. F. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0687-7 · Cited by 166

Astroglia as Metal Depots: Molecular Mechanisms for Metal Accumulation, Storage and Release

Tiffany‐Castiglioni, E., & Qian, Y. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00050-x · Cited by 166

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Du, G., Liu, T., Lewis, M. M., Kong, L., Wang, Y., Connor, J. R., Mailman, R. B., & Huang, X. (2015) · Movement Disorders · doi:10.1002/mds.26417 · Cited by 167

Iron accumulation in the substantia nigra in rats visualized by ultrasound

Berg, D., Grote, C., Rausch, W., Mäurer, M., Wesemann, W., Riederer, P. F., & Becker, G. (1999) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(99)00046-0 · Cited by 165

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

McNaught, K. S. P., & Olanow, C. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 166

Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders

DIMATTEO, V., Pierucci, M., Esposito, E., Crescimanno, G., Benigno, A., & Giovanni, G. D. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00921-7 · Cited by 161

Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases

Gu, M., Owen, A., Toffa, S., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., MARSDEN, C. D., & Schapira, A. H. V. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00095-1 · Cited by 164

Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease

Jenner, P. G. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb00013.x · Cited by 163

MRI assessment of basal ganglia iron deposition in Parkinson's disease

Wallis, L. I., Paley, M. N. J., Graham, J., Grünewald, R. A., Wignall, E. L., Joy, H. M., & Griffiths, P. D. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21563 · Cited by 161

Development of biomarkers for Huntington's disease

Weir, D. W., Sturrock, A., & Leavitt, B. R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70070-9 · Cited by 162

Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.

Dormont, D., Ricciardi, K. G., Tandé, D., et al. (2004) · PubMed · Cited by 161

Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease

Baudrexel, S., Nürnberger, L., Rüb, U., Seifried, C., Klein, J. C., Deller, T., Steinmetz, H., Deichmann, R., & Hilker, R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.005 · Cited by 167

Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration

Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 163

Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study

Zhang, J., Zhang, Y., Wang, J., Cai, P., Luo, C., Qian, Z., Dai, Y., & Feng, H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.036 · Cited by 158

Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping

Guan, X., Xuan, M., Gu, Q., Huang, P., Liu, C., Wang, N., Xu, X., Luo, W. F., & Zhang, M. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3489 · Cited by 162

Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation

Tsunemi, T., & Krainc, D. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt572 · Cited by 161

Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically

Agrawal, S., Fox, J. A., Thyagarajan, B., & Fox, J. H. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.002 · Cited by 155

Huntingtin-deficient zebrafish exhibit defects in iron utilization and development

Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156

Metal Ion Physiopathology in Neurodegenerative Disorders

Bolognin, S., Luigi Messori, A., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 159

Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding

Xiao, G., Fan, Q., Wang, X., & Zhou, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308535110 · Cited by 162

Oxidative Stress and Parkinson's Diseasea

Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 154

Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction

Park, J.-S., Koentjoro, B., Veivers, D., Mackay‐Sim, A., & Sue, C. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt623 · Cited by 160

The molecular and cellular basis of copper dysregulation and its relationship with human pathologies

Maung, M. T., Carlson, A., Olea‐Flores, M., Elkhadragy, L., Schachtschneider, K. M., Navarro‐Tito, N., & Padilla‐Benavides, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100273rr · Cited by 158

Microglial degeneration in the aging brain - bad news for neurons?

Streit, W. (2008) · Frontiers in Bioscience · doi:10.2741/2937 · Cited by 150

Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González‐Muñoz, M. J., de Bustos, F., Martínez‐Salio, A., Pareja, M. O., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050073 · Cited by 151

Homozygosity mapping of Hallervorden–Spatz syndrome to chromosome 20p12.3–p13

Taylor, T. D., Litt, M. J., Kramer, P., Pandolfo, M., Angelini, L., Nardocci, N., Davis, S., Pineda, M., Hattori, H., Flett, P. J., et al. (1996) · Nature Genetics · doi:10.1038/ng1296-479 · Cited by 149

Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging

Roth, G. S., Joseph, J. A., & Mason, R. P. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93902-a · Cited by 150

Fe(III)-Coordination Properties of Neuromelanin Components: 5,6-Dihydroxyindole and 5,6-Dihydroxyindole-2-carboxylic Acid

Charkoudian, L. K., & Franz, K. J. (2006) · Inorganic Chemistry · doi:10.1021/ic060014r · Cited by 147

Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease

Bergen, J. M. G. V., Hua, J., Unschuld, P. G., Lim, I. A. L., Jones, C. K., Margolis, R. L., Ross, C. A., van Zijl, P. C. M., & Li, X. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4617 · Cited by 140

Hydroxyl Radicals, Iron, Oxidative Stress, and Neurodegenerationa

Gutteridge, J. M. C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21805.x · Cited by 145

Prospective study of plasma urate and risk of Parkinson disease in men and women

Gao, X., O’Reilly, É. J., Schwarzschild, M. A., & Ascherio, A. (2016) · Neurology · doi:10.1212/wnl.0000000000002351 · Cited by 142

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts

Michaeli, S., Öz, G., Sorce, D. J., Garwood, M., Uǧurbil, K., Majestic, S., & Tuite, P. (2006) · Movement Disorders · doi:10.1002/mds.21227 · Cited by 141

Astrocyte functions in the copper homeostasis of the brain

Scheiber, I. F., & Dringen, R. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.017 · Cited by 142

Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson?s disease

Forte, G., Bocca, B., Senofonte, O., Petrucci, F., Brusa, L., Stanzione, P., Zannino, S., Violante, N., Alimonti, A., & Sancesario, G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0124-0 · Cited by 138

Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis

Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137

Binding of Iron to Neuromelanin of Human Substantia Nigra and Synthetic Melanin: An Electron Paramagnetic Resonance Spectroscopy Study

Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135

MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease

Kosta, P., Argyropoulou, M. I., Markoula, S., & Konitsiotis, S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0914-9 · Cited by 135

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics

Davies, K. M., Mercer, J. F. B., Chen, N., & Double, K. L. (2016) · Clinical Science · doi:10.1042/cs20150153 · Cited by 139

Oxidative Stress, Antioxidants and Neurodegenerative Diseases

Casetta, I., Govoni, V., & Granieri, E. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054065729 · Cited by 135

Bioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease

Binolfi, A., Quintanar, L., Bertoncini, C. W., Griesinger, C., & Fernández, C. O. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.004 · Cited by 133

Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence

Popescu, B. F. G., George, M. J., Bergmann, U., Garachtchenko, A., Kelly, M., McCrea, R. P. E., Luening, K., Devon, R. M., George, G. N., Hanson, A. D., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/3/012 · Cited by 133

Iron in the Brain: An Important Contributor in Normal and Diseased States

Piñero, D. J., & Connor, J. R. (2000) · The Neuroscientist · doi:10.1177/107385840000600607 · Cited by 132

Metal chelating ability and antioxidant properties of Curcumin-metal complexes – A DFT approach

Mary, C. P. V., Vijayakumar, S., & Shankar, R. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.022 · Cited by 137

Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy

Koga, S., & Dickson, D. W. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315813 · Cited by 130

Ferritin as an important player in neurodegeneration

Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., & Gałązka-Friedman, J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.016 · Cited by 131

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease

Jin, L., Wang, J., Zhao, L., Jin, H., Fei, G., Zhang, Y., Zeng, M., & Zhong, C. (2010) · Brain · doi:10.1093/brain/awq319 · Cited by 129

Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease

Hegde, M. L., Shanmugavelu, P., Vengamma, B., Rao, T. S., Menon, R. B., Rao, R. V., & Rao, K. S. J. (2004) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2004.09.003 · Cited by 129

Altered Glial Function Causes Neuronal Death and Increases Neuronal Susceptibility to 1‐Methyl‐4‐Phenylpyridinium‐ and 6‐Hydroxydopamine‐Induced Toxicity in Astrocytic/Ventral Mesencephalic Co‐Cultures

McNaught, K. S. P., & Jenner, P. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732469.x · Cited by 128

Alteration of Serum Concentrations of Manganese, Iron, Ferritin, and Transferrin Receptor Following Exposure to Welding Fumes Among Career Welders

Lu, L., Zhang, L.-L., Li, G. J., Guo, W., Liang, W.-N., & Zheng, W. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.09.001 · Cited by 127

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126

Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases

Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 129

Redox Reactions of the α-Synuclein−Cu2+ Complex and Their Effects on Neuronal Cell Viability

Wang, C., Liu, L., Zhang, L., Peng, Y., & Zhou, F. (2010) · Biochemistry · doi:10.1021/bi1010909 · Cited by 126

Iron dysregulation in Huntington's disease

Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 123

Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease

Spiegel, J., Hellwig, D., Möllers, M., Behnke, S., Jost, W. H., Fassbender, K. C., Samnick, S., Dillmann, U., Becker, G., & Kirsch, C. (2006) · Brain · doi:10.1093/brain/awl042 · Cited by 123

Differential Cytotoxicity of Mn(II) and Mn(III): Special Reference to Mitochondrial [Fe-S] Containing Enzymes

Chen, J., Tsao, G. C., Zhao, Q., & Zheng, W. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9245 · Cited by 123

Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders

Savoiardo, M., Girotti, F., Strada, L., & Ciceri, E. F. M. (1994) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6641-3_8 · Cited by 119

Early Life Stress, Depression And Parkinson’s Disease: A New Approach

Dallé, E., & Mabandla, M. V. (2018) · Molecular Brain · doi:10.1186/s13041-018-0356-9 · Cited by 131

Redox Regulation of Heat Shock Protein Expression by Signaling Involving Nitric Oxide and Carbon Monoxide: Relevance to Brain Aging, Neurodegenerative Disorders, and Longevity

Calabrese, V., Butterfield, D. A., Scapagnini, G., Stella, A. M. G., & Maines, M. D. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.444 · Cited by 122

Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease

Walter, U., Krolikowski, K., Tarnacka, B., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000161847.46465.b9 · Cited by 122

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

Dedman, D., Treffry, A., Candy, J., Taylor, G. A., Morris, C. M., Bloxham, C. A., Perry, R. H., Edwardson, J. A., & Harrison, P. M. (1992) · Biochemical Journal · doi:10.1042/bj2870509 · Cited by 121

Altered systemic iron metabolism in Parkinson's disease

Logroscino, G., Marder, K. S., Graziano, J. H., Freyer, G. A., Slavkovich, V. N., LoIacono, N. J., Cote, L. J., & Mayeux, R. P. (1997) · Neurology · doi:10.1212/wnl.49.3.714 · Cited by 118

Visceral responses induced on excitation of caudate nucleus, putamen and globus pallidus.

Ghosh, M., & Mg, G. (1976) · PubMed · Cited by 1

Susceptibility weighted imaging evaluation of brain iron content of gray nucleus in healthy people

Ni, M.-F. (2009) · Zhongguo yixue yingxiang jishu

MR measurement of the basal ganglia volume in the Tourette syndrome

Liao, K., Guiping, L., & Yang, B. (2014) · Zhonghua fangshexian yixue zazhi · doi:10.3760/cma.j.issn.1005-1201.2014.02.002 · Cited by 1

Normal Aging in the Basal Ganglia Evaluated by Eigenvalues of Diffusion Tensor Imaging

Wang, Q., Xu, X., & Zhang, M. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1862 · Cited by 49

Differential aging of the human striatum: a prospective MR imaging study.

Gunning‐Dixon, F. M., Head, D. M., McQuain, J., Acker, J. D., & Raz, N. (1998) · PubMed Central · Cited by 178